Exonhit says EHT 0202 could be 'major therapeutic breakthrough' in ... - Forbes
Exonhit says EHT 0202 could be 'major therapeutic breakthrough' in ... Forbes, NY - PARIS (Thomson Financial) - ExonHit Therapeutics' EHT 0202 compound could be a 'major therapeutic breakthrough' in the treatment of Alzheimer's disease, ... |
Original post: Exonhit says EHT 0202 could be 'major therapeutic breakthrough' in ... - Forbes by ©2008 Google at alzheimers treatment - Google News
Blog tag: Alzheimers treatment
Technorati tag: Alzheimers treatment